STRS Ohio’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277K Buy
29,300
+5,300
+22% +$50.6K ﹤0.01% 1441
2026
Q1
$219K Hold
24,000
– – ﹤0.01% 1466
2025
Q4
$179K Hold
24,000
– – ﹤0.01% 1580
2025
Q3
$161K Hold
24,000
– – ﹤0.01% 1645
2025
Q2
$159K Buy
24,000
+1,800
+8% +$12.8K ﹤0.01% 1735
2025
Q1
$203K Hold
22,200
– – ﹤0.01% 1503
2024
Q4
$233K Buy
22,200
+19,200
+640% +$227K ﹤0.01% 1456
2024
Q3
$35.9K Hold
3,000
– – ﹤0.01% 1844
2024
Q2
$17.3K Buy
+3,000
New +$16.5K ﹤0.01% 1899
2023
Q2
– Sell
-324,000
Closed -$346K – 1959
2023
Q1
$346K Buy
324,000
+279,500
+628% +$535K ﹤0.01% 1463
2022
Q4
$116K Buy
44,500
+42,600
+2,242% +$186K ﹤0.01% 1705
2022
Q3
$13K Sell
1,900
-26,200
-93% -$205K ﹤0.01% 1954
2022
Q2
$191K Buy
28,100
+1,600
+6% +$16.3K ﹤0.01% 1620
2022
Q1
$373K Sell
26,500
-7,612
-22% -$102K ﹤0.01% 1545
2021
Q4
$494K Buy
34,112
+4,112
+14% +$58.5K ﹤0.01% 1481
2021
Q3
$424K Sell
30,000
-11,300
-27% -$174K ﹤0.01% 1567
2021
Q2
$726K Buy
41,300
+39,500
+2,194% +$637K ﹤0.01% 1415
2021
Q1
$27K Buy
+1,800
New +$25.6K ﹤0.01% 2091

Other funds holding BVS

STRS Ohio's BVS Position: Q2 2026 in Review

STRS Ohio increased its Bioventus (BVS) stake by 22% in Q2 2026, buying an estimated $50.6K and bringing the position to 29,300 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #1441.

STRS Ohio first reported a position in BVS in Q1 2021 and has held it in 18 quarters since. The position peaked at $726K in Q2 2021. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • STRS Ohio held 29,300 shares of Bioventus worth $277K as of Q2 2026.
  • STRS Ohio bought 5,300 Bioventus shares in Q2 2026, an estimated $50.6K.
  • Bioventus made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1441 holding.
  • STRS Ohio first reported a position in Bioventus in Q1 2021 and has held it in 18 quarters since.
  • STRS Ohio's Bioventus position peaked at $726K in Q2 2021.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.